U.S. Markets closed

Pfizer Inc. (PFE)

New York Stock Exchange Consolidated Issue - New York Stock Exchange Consolidated Issue Delayed Price. Currency in USD
Add to watchlist
33.24+0.09 (+0.27%)
At close: 4:00PM EDT

33.20 -0.04 (-0.12%)
After hours: 4:17PM EDT

People also watch
MRKJNJJPMINTCGE
Full screen
Previous Close33.15
Open33.07
Bid33.26 x 100
Ask33.25 x 43400
Day's Range33.07 - 33.39
52 Week Range29.83 - 35.38
Volume15,862,708
Avg. Volume18,315,874
Market Cap197.69B
Beta1.05
PE Ratio (TTM)27.98
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.28 (3.91%)
Ex-Dividend Date2017-08-02
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters3 hours ago

    SAC Capital's Martoma fails to overturn U.S. insider trading conviction

    A divided federal appeals court on Wednesday upheld the insider trading conviction of Mathew Martoma, a former portfolio manager for billionaire Steven A. Cohen's SAC Capital Advisors LP, after the U.S. Supreme Court made such cases easier to pursue. The 2nd U.S. Circuit Court of Appeals in Manhattan found "overwhelming" evidence that a Michigan doctor received financial benefits from providing confidential information to Martoma about a 2008 Alzheimer's drug trial.

  • Pfizer's Ibrance in First-Line Combo Breast Cancer Study
    Zacks6 hours ago

    Pfizer's Ibrance in First-Line Combo Breast Cancer Study

    Pfizer, Inc. (PFE) and six international cancer research groups are collaborating on a combination study to explore the use of Ibrance for first-line treatment of advanced breast cancer.

  • Reuters6 hours ago

    U.S. appeals court upholds insider trading conviction of SAC's Martoma

    A divided federal appeals court on Wednesday upheld the insider trading conviction of Mathew Martoma, a former SAC Capital Advisors LP portfolio manager, rejecting his claims that there was inadequate ...